Literature DB >> 10914730

Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis.

K Tae1, A K El-Naggar, E Yoo, L Feng, J J Lee, W K Hong, W N Hittelman, D M Shin.   

Abstract

Angiogenesis is a fundamental process in tumor growth and metastasis, and its significance and that of vascular endothelial growth factor (VEGF) expression as prognostic indicators have been documented for various types of human tumors. However, the mechanisms responsible for angiogenesis in head and neck squamous cell carcinoma are not well defined. To examine the relationship between angiogenesis and the phenotypic progressions of head and neck tumorigenesis, we used immunohistochemistry to analyze VEGF expression and microvessel density in 70 paraffin-embedded specimens that contained adjacent normal epithelium, premalignant lesions, or both from 57 patients with head and neck squamous cell carcinoma. Ten samples of normal oral mucosa were obtained from people who did not smoke or drink alcohol and included in the analysis as normal controls. Microvessel density was evaluated by averaging 10 microscopic fields (x400) in a defined area of each specimen. The degree of VEGF expression was assessed on a cell-by-cell basis in 10 microscopic fields (x200) in a defined area on a scale ranging from 0 (no expression) to 3+ (highest level of expression). In addition, the weighted mean index of VEGF expression was calculated. The mean +/- SD weighted mean index of VEGF expression in normal control epithelium (1.10 +/- 0.38, n = 10) was higher than it was in adjacent normal epithelium (0.82 +/- 0.27, n = 13; P = 0.04). VEGF expression decreased as samples ranged from normal adjacent epithelium to hyperplasia (0.78 +/- 0.28, n = 21), mild dysplasia (0.70 +/- 0.29, n = 28), moderate dysplasia (0.67 +/- 0.29, n = 11), severe dysplasia (0.51 +/- 0.39, n = 6), and squamous cell carcinoma (0.20 +/- 0.27, n = 70; overall P = 0.0001). VEGF expression was two times lower in cases with nodal disease (0.17 +/- 0.26, n = 29) than it was in nonnodal disease (0.32 +/- 0.29, n = 16; P = 0.02). Microvessel density showed no significant difference from adjacent normal epithelium premalignant lesions to cancer. In tumor, no correlation was seen between VEGF expression or microvessel density and differentiation, primary tumor site, T stage, or smoking status. These findings indicate that VEGF expression is down-regulated during head and neck tumorigenesis. However, further studies are required to better understand the mechanism of VEGF down-regulation in head and neck tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10914730

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  37 in total

1.  Intraepithelially entrapped blood vessels in oral carcinoma in-situ.

Authors:  Akinori Funayama; Satoshi Maruyama; Manabu Yamazaki; Kamal Al-Eryani; Susumu Shingaki; Chikara Saito; Jun Cheng; Takashi Saku
Journal:  Virchows Arch       Date:  2012-04-05       Impact factor: 4.064

Review 2.  Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma.

Authors:  Giovana R Thomas; Hari Nadiminti; Jacinto Regalado
Journal:  Int J Exp Pathol       Date:  2005-12       Impact factor: 1.925

3.  Autofluorescence and diffuse reflectance spectroscopy of oral epithelial tissue using a depth-sensitive fiber-optic probe.

Authors:  Richard A Schwarz; Wen Gao; Dania Daye; Michelle D Williams; Rebecca Richards-Kortum; Ann M Gillenwater
Journal:  Appl Opt       Date:  2008-02-20       Impact factor: 1.980

4.  Increased glucose metabolism by FDG-PET correlates with reduced tumor angiogenesis in oral squamous cell carcinoma.

Authors:  Mikiko Nakamura; Yoshimasa Kitagawa; Yutaka Yamazaki; Hironobu Hata; Motoko Kotsuji; Yasuhisa Fujibayashi; Hidehiko Okazawa; Yoshiharu Yonekura; Kazuo Sano
Journal:  Odontology       Date:  2011-05-13       Impact factor: 2.634

5.  Angiogenesis in oral squamous cell carcinoma.

Authors:  G Ascani; P Balercia; M Messi; L Lupi; G Goteri; A Filosa; D Stramazzotti; T Pieramici; C Rubini
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-02       Impact factor: 2.124

6.  Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma.

Authors:  Panayiotis A Kyzas; Dimitrios Stefanou; Anna Batistatou; Niki J Agnantis
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

7.  Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications.

Authors:  Rifat Hasina; Mark E Whipple; Leslie E Martin; Winston Patrick Kuo; Lucila Ohno-Machado; Mark W Lingen
Journal:  Lab Invest       Date:  2008-02-18       Impact factor: 5.662

8.  Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts.

Authors:  Elin Hadler-Olsen; Hilde Ljones Wetting; Oddveig Rikardsen; Sonja E Steigen; Premasany Kanapathippillai; Reidar Grénman; Jan-Olof Winberg; Gunbjørg Svineng; Lars Uhlin-Hansen
Journal:  Virchows Arch       Date:  2010-10-03       Impact factor: 4.064

9.  Poor prognostic clinicopathologic features correlate with VEGF expression but not with PTEN expression in squamous cell carcinoma of the larynx.

Authors:  Yurdanur Sullu; Seda Gun; Sinan Atmaca; Filiz Karagoz; Bedri Kandemir
Journal:  Diagn Pathol       Date:  2010-06-14       Impact factor: 2.644

10.  The relevance of mast cells in oral squamous cell carcinoma.

Authors:  Vineet Singh Cheema; V Ramesh; P D Balamurali
Journal:  J Clin Diagn Res       Date:  2012-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.